anti-inflammatory peptides (Agennix)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Nameanti-inflammatory peptides (Agennix)
Drug Alias NameAGX-P21AGX-P23
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAgennix
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAgennix
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A